Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gram-positive cell wall anionic polymers, primarily wall teichoic acids (WTAs) and lipoteichoic acids (LTAs), are essential glycopolymers that constitute a significant portion of the Gram-positive bacterial cell envelope (Swoboda et al., 2010, PMID: 20039316). WTAs are covalently linked to peptidoglycan, while LTAs are anchored to the cytoplasmic membrane; both are critical for maintaining cell wall integrity, regulating ion homeostasis, and controlling the activity of autolytic enzymes (Brown et al., 2013, PMID: 23384483). These polymers also play a central role in pathogenesis by mediating bacterial adhesion to host tissues and promoting the formation of biofilms (Weidenmaier & Peschel, 2008, PMID: 18354395). Because they are essential for the viability and virulence of major pathogens like Staphylococcus aureus, they are attractive targets for antimicrobial therapy. Drugs such as Teixobactin target WTA precursors, while others like Daptomycin interact with LTAs to disrupt membrane function, and biosynthetic inhibitors like Targocil can restore sensitivity to conventional antibiotics (Ling et al., 2015, PMID: 25561178; Campbell et al., 2011, PMID: 21390154).
Inhibition of teichoic acid biosynthesis (e.g., TarO or TarG inhibition), binding to lipid-linked precursors (Lipid III), or disruption of membrane integrity through interaction with lipoteichoic acids (Swoboda et al., 2010, PMID: 20039316; Ling et al., 2015, PMID: 25561178).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gram-positive cell wall anionic polymers (Teichoic acids) (WTA/LTA).